BlackRock Group Form 8.3 - Willis Towers Watson Plc (4281S)

TIDM0Y4Q

RNS Number : 4281S

BlackRock Group

08 July 2020

Ap19

   FORM   8.3 
   IRISH  TAKEOVER   PANEL 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH  TAKEOVER   PANEL ACT,  1997,  TAKEOVER  RULES, 2013 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.       KEY   INFORMATION 
 
Name of person dealing      BlackRock, Inc. 
 (Note 1) 
Company dealt in            Willis Towers Watson plc 
                            ======================== 
Class of relevant security  US$0.000304635 ordinary 
 to which the dealings       shares 
 being disclosed relate 
 (Note 2) 
                            ======================== 
Date of dealing             07 July 2020 
                            ======================== 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant

security   dealt   in   (Note   3) 
 
                                          Long                Short 
                             Number        (%)     Number       (%) 
                             ===========  ======  ===========  ====== 
(1) Relevant securities       9,734,472 (7.56%)        0 (0.00%) 
                             ===================  =================== 
(2) Derivatives (other 
 than options)                 138,273 (0.10%)       7,173 (0.00%) 
                             ===================  =================== 
(3) Options and agreements 
 to purchase/sell                 0 (0.00%)         20,900 (0.01%) 
                             ===================  =================== 
Total                         9,872,745 (7.66%)     28,073 (0.02%) 
                             ===================  =================== 
 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt

  in   (Note   3) 
 
Class of relevant security:                Long                Short 
                              Number        (%)     Number         (%) 
                              =========    ======  ===========    ====== 
(1) Relevant securities 
                              ===================  ===================== 
 
  (2) Derivatives (other 
  than options) 
                              ===================  ===================== 
 
  (3) Options and agreements 
  to purchase/sell 
                              ===================  ===================== 
Total 
                              ===================  ===================== 
 
 

Ap20

   1.       DEALINGS  (Note   4) 
   (a)      Purchases and sales 
 
 
  Purchase/sale           Number of relevant securities        Price per unit 
                                                               (Note 5) 
Purchase         210                                     USD 196.5800 
                 ======================================  ==================== 
Purchase         2,016                                   USD 197.3327 
                 ======================================  ==================== 
Purchase         3                                       USD 197.4933 
                 ======================================  ==================== 
Sale             21,052                                  USD 196.5800 
                 ======================================  ==================== 
Sale             5                                       USD 197.2970 
                 ======================================  ==================== 
Sale             5,907                                   USD 197.3389 
                 ======================================  ==================== 
Sale             34,270                                  USD 197.4904 
                 ======================================  ==================== 
Sale             270                                     USD 197.8507 
                 ======================================  ==================== 
 

Please note: there was also a Transfer In of 3,716 Shares

   (b)      Derivatives transactions (other than options transactions) 
 
Product    Nature of transaction  Number of relevant   Price per 
 name,      (Note 6)               securities           unit 
 e.g. CFD                          (Note 7)             (Note 5) 
CFD        Reducing Long          1,770               USD 197.4427 
           =====================  ==================  ============ 
CFD        Reducing Long          560                 USD 197.4984 
           =====================  ==================  ============ 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing,  selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money paid/received 
 e.g. call   purchasing,   to which                  European                 per unit 
 option      varying       the option                etc.                     (Note 5) 
             etc.          relates (Note 
                           7) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     5) 
 
 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 
Nature of transaction         Details      Price per unit 
 (Note 8)                                   (if applicable) 
                                            (Note 5) 
Return of Stock        700             N/A 
 on Loan 
                       ==============  ==================== 
 

Ap21

   2.       OTHER  INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or

  relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any 

relevant securities to which any derivative referred to on this form is referenced.

   If none, this should   be   stated. 

None

   Is a Supplemental Form 8 attached?  (Note   9)                                     YES 
 
Date of disclosure            08 July 2020 
Contact name                  Jana Blumenstein 
                              ================ 
Telephone number              [phone] 
                              ================ 
If a connected EFM, name 
 of offeree/offeror with 
 which connected 
                              ================ 
If a connected EFM, state 
 nature of connection (Note 
 10) 
                              ================ 
 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

   OPEN POSITIONS  (Note   1) 
 
 Product      Written,        Number of relevant     Exercise      Type, e.g.   Expiry 
  name,        or purchased    securities             price         American,    date 
  e.g. call                    to which the           (Note         European 
  option                       option or derivative   2)            etc. 
                               relates 
Call Option  Written         10,500                  USD 200.0000  American    17/07/2020 
             ==============  ======================  ============  ==========  ========== 
Call Option  Written         10,400                  USD 210.0000  American    21/08/2020 
             ==============  ======================  ============  ==========  ========== 
 

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full

details   should   be   given.   Full 

details of any existing agreements to purchase or to sell must also be given on this form.

   2.          For all prices and other monetary amounts, the currency must be   stated. 

For full details of disclosur e requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

ISERPMTTMTMMBAM

(END) Dow Jones Newswires

July 08, 2020 10:20 ET (14:20 GMT)